Last updated: September 22, 2023
Sponsor: Botiss Medical AG
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
Biopsy
GBR surgery including membrane placement
Clinical Study ID
NCT06059898
NM-MEM-01
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Obtained informed consent from the patient, patients voluntarily signing the informedconsent form before study related actions including patient's acceptance of thescheduled program of clinical and radiographic analysis
- The patient shall be at least 18 years of age, male or female and have passedcessation of growth
- Patients asking for more than one dental implant and presenting one site with a healedsite (class h1i, h2i; h3i, v1i, c1i, h1e, h2e, h3e, Cologne Classification of AlveolarRidge Defects (CCARD) requiring a GBR procedure prior to implant placement.
- The teeth at the implant site must have been extracted or lost at least 8 weeks beforethe date of bone augmentation (volumetrically healed site)
Exclusion
Exclusion Criteria: Systemic exclusion criteria
- Major systemic diseases (e.g. recent myocardial infarction, cerebrovascular accidentor valvular prosthesis surgery, a poorly stabilized diabetes mellitus, severehypertension, severe peripheral artery occlusive disease, malignancies, autoimmunediseases, or kidney diseases, untreated or uncontrolled periodontal disease,uncontrolled drug or alcohol abuse, uncontrolled psychiatric disorders)
- Acute infectious diseases
- Immunocompromised patients
- Serious disturbances of bone metabolism and/or serious bone diseases of endocrineetiology
- Due to judgement of the principal investigator: Medical conditions requiring prolongeduse of steroids and/or on-going treatment with gluco- and mineralocorticoids and withagents affecting calcium metabolism (e.g. calcitonin), and/or anti-coagulative therapy
- Previous or current use of antiresorptive medication (e.g. bisphosphonates)
- Previous oral / maxillofacial radiotherapy
- Heavy smoker (definition: >10 cigarettes per day)
- Currently pregnant or breastfeeding women
- Health conditions, which do not permit the surgical treatment Local exclusion criteria
- Acute local inflammation or untreated periodontitis
- Insufficient oral hygiene
- Regenerative periodontal treatment necessary adjacent to the planned study site ofinterest
- Mucosal diseases or oral white or ulcerative lesions (e.g. lichen planus, leukoplakia)
- History of head and neck irradiation therapy
- Severe bruxism or clenching or other destructive habits
- Previous socket preservation, GBR or guided tissue regeneration (GTR) treatment at theimplant site
- Infections in tissue and adjacent tissue of the planned implantation site
- Known hypersensitivity to any of the trace elements
- Edentulous cases
Study Design
Total Participants: 84
Treatment Group(s): 2
Primary Treatment: Biopsy
Phase:
Study Start date:
April 08, 2022
Estimated Completion Date:
November 01, 2023
Study Description
Connect with a study center
Medical University of Graz Department of Dental Medicine and Oral Health
Graz, 8010
AustriaActive - Recruiting
University of Vienna, Department of Oral Surgery
Vienna, 1090
AustriaActive - Recruiting
Copenhagen University Hospital, Department of Oral & Maxillofacial Surgery
Copenhagen, 2100
DenmarkActive - Recruiting
Studio Tabanella
Roma, 00198
ItalyActive - Recruiting
Studio medico odontoiatrico Papi Stp Srl
Roma, 00176
ItalyActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.